Tuesday, April 17, 2007

BMS - Erbitux: clinical trials, ain't they a bitch

ImClone Systems and Bristol-Myers Squibb said Monday results of a late-stage study showed Erbitux and chemotherapy combined failed to meet their primary goal as a colon cancer treatment.

In November, the companies said cancer drug Erbitux, in combination with irinotecan, failed to extend overall survival in patients who had received previous treatment.

Source

No comments: